Medical Treatments for Prostate CancerThere are many different medical treatments for prostate cancer that involve the clinical care of a healthcare professional. These treatments include expectant therapy, surgery, radiation therapy, hormone therapy, and chemotherapy. Expectant therapy is to carefully observe and monitor the prostate cancer. Because prostate cancer cells often spread very slowly, many older men who have the disease may not need more extensive treatment. However, expectant therapy usually includes routine physician examinations, including digital rectal exams and PSA tests. The different types of surgery for prostate cancer are radical prostatectomy - an open-surgery procedure in which the entire prostate gland and surrounding tissue are removed. Transurethral resection of the prostate (TURP) - surgery to remove part of the prostate gland that surrounds the urethra. Cryosurgery - this procedure involves killing the cancer cells by freezing them with a small metal tool placed in the tumor. Side effects of prostate cancer surgery include incontinence and impotence. Incontinence is the inability to control urine and may result in dribbling of urine, especially immediately after surgery. Normal control usually returns within weeks or months after surgery. Impotence is the inability to achieve an erection. For a month, or so, after surgery, most men are not able to get an erection. Eventually, approximately 40 to 60 percent of men will be able to get an erection sufficient for sexual intercourse, but without ejaculation of semen, since removal of the prostate gland prevents that process.Radiation therapy uses high energy rays to kill or shrink cancer cells, and to decrease their ability to divide. Radiation is often used to treat prostate cancer that is still confined to the prostate gland, or has spread only to nearby tissue. If the disease is advanced, radiation may be used to reduce the size of the tumor and to provide relief from symptoms. Possible side effects of radiation for prostate cancer may include diarrhea, with or without blood in the stool, and colitis, problems associated with urination, a degree of impotence (inability to get an erection), which may occur within two years of radiation therapy. The goal of hormone therapy is to lower the level of male hormones in the body, particularly testosterone. Hormone therapy does not cure the cancer, and is often used to treat persons whose cancer has spread or recurred after treatment. Produced mainly in the testicles, testosterone causes prostate cancer cells to grow. Thus, reduced testosterone levels can make the prostate cancer shrink and become less active. Most studies show that hormone therapy works better if it is started early. Chemotherapy is the use of powerful, anti-cancer medications to kill cancer cells.. Hospitalization may be needed to monitor treatment and chemotherapy's side effects. Common side effects of chemotherapy include: nausea and vomiting, hair loss, anemia, reduced ability of blood to clot, mouth sores, increased likelihood of developing infections, fatigue. Most side effects disappear once treatment is stopped. |
| advanced prostate cancer survival |
|
Improved survival in patients with locally advanced prostate Improved survival in patients with locally advanced prostate cancer treated Kaplan-Meier estimates of overall survival at five years were 79 percent (95 Experimental Drug Extends Overall Survival in Men With Advanced Early research studies show that patients with advanced prostate cancer given AstraZeneca's experimental pill ZD4054 lived around seven months longer than JAMA -- Abstract: Adjuvant Radiotherapy for Pathologically Patients were 425 men with pathologically advanced prostate cancer who had undergone For metastasis-free survival, 76 (35.5%) of 214 men in the adjuvant NEJM -- Improved Survival in Patients with Locally Advanced Original Article from The New England Journal of Medicine -- Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy Postgraduate Medicine: Prostate Cancer Symposium: Advanced Advanced prostate cancer can be a devastating clinical condition, so survival, and hence the period of treatment, is even more prolonged. ACS :: Targeted Bone Therapy May Aid Prostate Cancer Survival Patients with advanced prostate cancer who respond to chemotherapy may have a better chance at survival if they undergo therapy targeted at bone metastases, UpToDate Patient information: Advanced prostate cancer Docetaxel plus prednisone or mitoxantrone for advanced prostate cancer: Updated survival of the TAX 327 study (abtract). J Clin Oncol 2007; 25:236s. Provenge Significantly Improves Survival Advanced Prostate Cancer Provenge Significantly Improves Survival Advanced Prostate Cancer :From MedicineWorld.Org. Your gateway to the world of medicine. 'Inoperable' advanced prostate cancer may be operable, curable 'Inoperable' advanced prostate cancer may be operable, curable The cancer survival rates for cT3 prostate cancer with radical prostatectomy not only Taxotere improves survival in advanced prostate cancer - The Researchers conclude that these long term results continue to provide evidence that Taxotere based therapy improves survival for advanced prostate cancer Anemia Linked To Advanced Prostate Cancer Survival Worsening Anemia Signals Poorer Outcomes In Men Treated For Advanced Prostate Cancer (May 23, 2006) Dendreon: Dendreon's Provenge Extends Survival in Advanced Dendreon's Provenge Extends Survival in Advanced Prostate Cancer by Over Eight Months in Patients with Gleason Scores of Seven and Less Drug could slow growth of advanced prostate cancer - USATODAY.com Prostate cancer survival rates The importance of early prostate cancer detection chemotherapy drug could give some men with advanced prostate cancer a Treatment of advanced prostate cancer, from the Prostate Cancer (The longest period which we have heard of a patient surviving with advanced prostate cancer is 26 years. However, this length of survival with advanced eMedicine - Prostate Cancer: Metastatic and Advanced Disease Bolla M, Gonzalez D, Warde P, et al: Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. Prognosis of Prostate Cancer - WrongDiagnosis.com 8: 2211-2219, American Cancer Society); 26 months is the median survival for patients with advanced prostate cancer who are still alive two years after PSA Predicts Prostate Cancer Survival How long a man survives with advanced prostate cancer may be predicted by PSA Metastatic Prostate Cancer Survival Related to PSA Drop After Treatment Prostate Cancer Vaccine Is First To Increase Survival The UCSF-led study is the first to demonstrate a survival benefit from immunologic therapies or vaccines in patients with advanced prostate cancer. Mayo Clinic Study Shows Advanced Prostate Cancer Previously The cancer survival rates for cT3 prostate cancer with radical prostatectomy not only told that they had a cT3 prostate cancer, a more advanced form, |
| advanced prostate cancer survival |
|
brochure cancer prostate beta prostate sitosterol age exam prostate cancer opinion prostate second |